Carmona-Bayonas 2017 EPIPHANY CHAID tree for cancer-associated PE
Carmona-Bayonas 2017 EPIPHANY CHAID tree for cancer-associated PE. Hestia-like CDR any vs none, then ECOG-PS, SaO2, PE symptoms, tumour response, and primary resection as in Figure 2. Returns low, intermediate, or high with 15-day complication rates 1.6/9.4/3…
by api.magentlab.com · discovered, not yet claimed by its owner · updated 2026-10-13
Mirrored from Coinbase's public x402 Bazaar. The description is the provider's own text and has not been reviewed here; the payment requirements are copied as published.
What it does
Carmona-Bayonas 2017 EPIPHANY CHAID tree for cancer-associated PE. Hestia-like CDR any vs none, then ECOG-PS, SaO2, PE symptoms, tumour response, and primary resection as in Figure 2. Returns low, intermediate, or high with 15-day complication rates 1.6/9.4/30.6% and mortality 0.3/6.1/17.1%. Caller assigns the six covariates. Not a diagnosis or anticoagulation order. magent does not examine the patient.
Tags: epiphany · pe · cancer · vte · calculator · bazaar
Call contract
- Method
- POST
- Input
- HTTP request
- Output
- json
- Last paid call
- 2026-10-13
{
"items": [
{
"ecog_ps_ge_2": false,
"hestia_like_any": false,
"oxygen_sat_lt_90": false,
"pe_specific_symptoms": false,
"primary_tumour_resected": true,
"tumour_uncontrolled": false
},
{
"ecog_ps_ge_2": false,
"hestia_like_any": false,
"oxygen_sat_lt_90": false,
"pe_specific_symptoms": false,
"primary_tumour_resected": true,
"tumour_uncontrolled": false
}
]
}{
"count": 2,
"items": [
{
"citation": {
"authors": "Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C, Plasencia JM, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, de la Haba I, Antonio M, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, Ayala de la Peña F, Vicente V; Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia",
"doi": "10.1038/bjc.2017.48",
"id": "carmona-bayonas-2017",
"pmid": "28267709",
"source": "Br J Cancer. 2017;116:994-1001",
"title": "Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index"
},
"criteria": [
{
"factor": "hestia_like_any",
"met": false
},
{
"factor": "ecog_ps_ge_2",
"met": false
},
{
"factor": "oxygen_sat_lt_90",
"met": false
},
{
"factor": "pe_specific_symptoms",
"met": false
},
{
"factor": "tumour_uncontrolled",
"met": false
},
{
"factor": "primary_tumour_resected",
"met": true
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"ecog_ps_ge_2": false,
"formula": "epiphany",
"formula_expression": "root: hestia-like CDR any vs none (Carmona-Bayonas 2017 Figure 2). CDR any: ECOG-PS >=2 then SaO2 <90 vs >=90 (both high), else PE-specific symptoms yes (high) vs no (intermediate). CDR none: tumour progression/unknown/not evaluated vs others (CR/PR/SD/NED); if uncontrolled then primary tumour resection yes (low) vs no (intermediate); if others then low. Classes low/intermediate/high with 15-day serious complications 1.6/9.4/30.6% and 15-day mortality 0.3/6.1/17.1%",
"hestia_like_any": false,
"leaf": "low_controlled",
"mortality_15d_percent": 0.3,
"oxygen_sat_lt_90": false,
"pe_specific_symptoms": false,
"primary_tumour_resected": true,
"risk_class": "low",
"serious_complication_15d_percent": 1.6,
"tumour_uncontrolled": false
},
{
"citation": {
"authors": "Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C, Plasencia JM, Biosca M, Sánchez M, Benegas M, Calvo-Temprano D, Varona D, Faez L, de la Haba I, Antonio M, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, Ayala de la Peña F, Vicente V; Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia",
"doi": "10.1038/bjc.2017.48",
"id": "carmona-bayonas-2017",
"pmid": "28267709",
"source": "Br J Cancer. 2017;116:994-1001",
"title": "Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index"
},
"criteria": [
{
"factor": "hestia_like_any",
"met": false
},
{
"factor": "ecog_ps_ge_2",
"met": false
},
{
"factor": "oxygen_sat_lt_90",
"met": false
},
{
"factor": "pe_specific_symptoms",
"met": false
},
{
"factor": "tumour_uncontrolled",
"met": false
},
{
"factor": "primary_tumour_resected",
"met": true
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"ecog_ps_ge_2": false,
"formula": "epiphany",
"formula_expression": "root: hestia-like CDR any vs none (Carmona-Bayonas 2017 Figure 2). CDR any: ECOG-PS >=2 then SaO2 <90 vs >=90 (both high), else PE-specific symptoms yes (high) vs no (intermediate). CDR none: tumour progression/unknown/not evaluated vs others (CR/PR/SD/NED); if uncontrolled then primary tumour resection yes (low) vs no (intermediate); if others then low. Classes low/intermediate/high with 15-day serious complications 1.6/9.4/30.6% and 15-day mortality 0.3/6.1/17.1%",
"hestia_like_any": false,
"leaf": "low_controlled",
"mortality_15d_percent": 0.3,
"oxygen_sat_lt_90": false,
"pe_specific_symptoms": false,
"primary_tumour_resected": true,
"risk_class": "low",
"serious_complication_15d_percent": 1.6,
"tumour_uncontrolled": false
}
],
"path": "/api/calc/epiphany"
}Use with an agent
- Discover. Agents find this listing with
GET https://bazaar.saylorinnovations.com/discovery/search?query=…, the MCP toolsearch_resources, or/discovery/resources. - Inspect. Fetch
/resources/39188.jsonfor the price and payment options. - Pay. Call
GET https://api.magentlab.com/api/calc/epiphany. The provider answers402with its payment requirements. An x402 client signs one of the options below and retries withPAYMENT-SIGNATURE. - Execute. The provider returns
200with the data. Agent Bazaar is not in the request path and never sees your payment.
For humans
You don't need an account or an API key; you need a wallet holding a small amount of USDC on Base, and an x402-capable client (see the examples below). Call the endpoint unpaid first to see exactly what it asks for.
Pricing & payment
- Price
- $0.005 / request
- Protocol
- x402 v2
- Auth
- No account or API key. Pay per request.
- Networks
- Base
- Demand
- 5 calls · 2 unique payers in 30d (public x402 Bazaar data)
x402 payment requirements
| Scheme | Network | Asset | Amount | Pay to | Timeout |
|---|---|---|---|---|---|
| exact | Base eip155:8453 | USDC | $0.005 | 0x836Be278f1739fB4308091cD1852F7971Bc19Ee2 | 600s |
accepts[] (raw JSON)
[
{
"scheme": "exact",
"network": "eip155:8453",
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"amount": "5000",
"amountUsd": 0.005,
"maxTimeoutSeconds": 600
}
]Schemas
Output schema (JSON Schema)
{
"properties": {
"example": {
"type": "object"
},
"type": {
"type": "string"
}
},
"required": [
"type"
],
"type": "object"
}Example shape — generated from the schema, not a captured live response
{
"example": {},
"type": "string"
}Examples
curl "https://api.magentlab.com/api/calc/epiphany"
# -> 402 Payment Required, accepts[] lists how to pay
# retry with a PAYMENT-SIGNATURE (or PAYMENT header) once paidconst res = await fetch("https://api.magentlab.com/api/calc/epiphany");
if (res.status === 402) {
const { accepts } = await res.json();
// pay one of accepts[] via an x402 client, then retry with the payment header
}import httpx
res = httpx.get("https://api.magentlab.com/api/calc/epiphany")
if res.status_code == 402:
accepts = res.json()["accepts"]
# pay one of accepts[] via an x402 client, then retry with the payment headerDetails
- Provider
- api.magentlab.com
- Endpoint
- https://api.magentlab.com/api/calc/epiphany
- Machine-readable
/resources/39188.json